Next-generation sequencing (NGS) has revolutionized extraction of genomic information, facilitating rapid advances in the fields of clinical research and molecular diagnostics. However, certain bottlenecks still pose challenges in implementing NGS for clinical research. To meet these challenges, QIAGEN introduced 14 panels for targeted enrichment of up to 570 clinically-relevant genes, the largest portfolio of panels for assessing cancer genes in a clinical research setting. GeneRead DNAseq Gene Panel V2 integrates with bioinformatics solutions, allowing customization of assays and streamlined data analysis and interpretation for fast generation of valuable insights. This webinar will discuss the utilization of these panels highlighting their analytical performance and applicability in a clinical research setting.